BRF
AVXL icon

B. Riley Financial’s Anavex Life Sciences AVXL Stock Holding History

B. Riley Financial’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-24,000
Closed -$81K – 51
2019
Q2 		$81K Sell
24,000
-91,000
-79% -$283K 0.04% 41
2019
Q1 		$351K Buy
+115,000
New +$275K 0.14% 35

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

B. Riley Financial's AVXL Position: Q3 2019 in Review

B. Riley Financial sold out of Anavex Life Sciences (AVXL) in Q3 2019, closing a stake of 24,000 shares — an estimated $81K sold.

B. Riley Financial first reported a position in AVXL in Q1 2019 and held it in 2 quarters. The position peaked at $351K in Q1 2019. 61 funds tracked by Wall St. Rank hold AVXL as of Q3 2019.

  • B. Riley Financial reported no remaining Anavex Life Sciences position as of Q3 2019 after selling out during the quarter.
  • B. Riley Financial sold 24,000 Anavex Life Sciences shares in Q3 2019, an estimated $81K.
  • B. Riley Financial first reported a position in Anavex Life Sciences in Q1 2019 and held it in 2 quarters.
  • B. Riley Financial's Anavex Life Sciences position peaked at $351K in Q1 2019.
  • 61 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2019.

Based on B. Riley Financial's 13F filing for Q3 2019, filed 14 Nov 2019.